All The Wrong Records


Headlines say borrowing costs are at a 16-year high and all stock picks are 82% BUY, 8% HOLD and 10% SELL.


1. BUY Moonpig

Top interesting stock pick this week is BUY Moonpig Group by Canaccord Genuity with a tip performance of 9%.

The red line of descent is more than apparent looking at the all-time Moonpig share price graph. Having listed at 424p in 2021 the online greeting card manufacturer sits today at 157p.

Canaccord Genuity reiterated their rating and target price on Monday. The Thursday before Moonpig announced results – revenue is up but profit is down.

Four out of five analysts in Stockomendation rate Moonpig as a BUY: they are Canaccord Genuity, John Choong, Berenberg and Jefferies. Only Daniel Liberto says HOLD. There are 9 short positions currently open, you can see more information here.


2. AVOID Strix

Second top stock pick this week is AVOID Strix Group by Steve Moore in ShareProphets with a tip performance of 8%.

Isle of Man kettle safety controls provider Strix Group’s share price is another stock which is a shadow of its former self, having opened at 134p in 2017 and now sitting at 95p. It wouldn’t seem like such a drop except for the dizzying heights of an all-time high at 382p quite recently in 2021.

Institutional owners have 51% of stock and performance is in line with market expectations according to the latest results. However, Steve Moore is cautiously pessimistic about the group’s reporting, results and future.

It’s a mixed bag amongst the experts with Steve Moore saying AVOID and Shore Capital and Roland Head with BUY. There are 4 short positions currently open, you can see more information here.


3. BUY Hammerson

Third interesting top stock pick this week is BUY Creo Medical Group by Ben McPoland in The Motley Fool with a tip performance of 7%.

Creo medical produces endoscopic medical devices. It listed at 77p in 2016 and is now at 37p.

In recent announcements its product was used for the first time in an upper gastrointestinal procedure which was a major milestone.

It raised £33.7mln this April to continue research for further product development.

Three out of three analysts in Stockomendation rate it as a BUY and there are no active short positions currently open.


UK Fund Manager Short Positions
See which UK Fund Managers are betting against your investments by accessing current & historical short positions on UK companies showing you which fund manager has shorted which company and by how much.

Join Now

CASH PRIZES ARE BACK!
Think you can pick stocks? Play the June league UK Share Picking game FREE for your chance to win cash prices : uksharepickinggame.co.uk


Disclaimer: The contents of this article should not be considered financial advice. Pricing data correct as at 6th July 2023.